208 related articles for article (PubMed ID: 29770901)
21. DosOpt: A Tool for Personalized Bayesian Dose Adjustment of Vancomycin in Neonates.
Tasa T; Metsvaht T; Kalamees R; Vilo J; Lutsar I
Ther Drug Monit; 2017 Dec; 39(6):604-613. PubMed ID: 29084032
[TBL] [Abstract][Full Text] [Related]
22. Clinical Utility and Safety of a Model-Based Patient-Tailored Dose of Vancomycin in Neonates.
Leroux S; Jacqz-Aigrain E; Biran V; Lopez E; Madeleneau D; Wallon C; Zana-Taïeb E; Virlouvet AL; Rioualen S; Zhao W
Antimicrob Agents Chemother; 2016 Apr; 60(4):2039-42. PubMed ID: 26787690
[TBL] [Abstract][Full Text] [Related]
23. Vancomycin: pharmacokinetics and administration regimens in neonates.
de Hoog M; Mouton JW; van den Anker JN
Clin Pharmacokinet; 2004; 43(7):417-40. PubMed ID: 15139793
[TBL] [Abstract][Full Text] [Related]
24. Microanalysis of beta-lactam antibiotics and vancomycin in plasma for pharmacokinetic studies in neonates.
Ahsman MJ; Wildschut ED; Tibboel D; Mathot RA
Antimicrob Agents Chemother; 2009 Jan; 53(1):75-80. PubMed ID: 18955527
[TBL] [Abstract][Full Text] [Related]
25. Vancomycin dosing in children and young adults: back to the drawing board.
Camaione L; Elliott K; Mitchell-Van Steele A; Lomaestro B; Pai MP
Pharmacotherapy; 2013 Dec; 33(12):1278-87. PubMed ID: 24019205
[TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetics of vancomycin in neonates admitted to the neonatology unit at the Jordan University Hospital.
Badran EF; Shamayleh A; Irshaid YM
Int J Clin Pharmacol Ther; 2011 Apr; 49(4):252-7. PubMed ID: 21429439
[TBL] [Abstract][Full Text] [Related]
27. [Design and validation of a dosing algorithm for vancomycin in premature neonates].
Juan Aguilar M; Ferriols Lisart R; Tosca Segura R; Alós Almiñana M
An Pediatr (Barc); 2008 Feb; 68(2):117-23. PubMed ID: 18341876
[TBL] [Abstract][Full Text] [Related]
28. Total flucloxacillin plasma concentrations poorly reflect unbound concentrations in hospitalized patients with Staphylococcus aureus bacteraemia.
Chin PKL; Drennan PG; Gardiner SJ; Zhang M; Dalton SC; Chambers ST; Begg EJ
Br J Clin Pharmacol; 2018 Oct; 84(10):2311-2316. PubMed ID: 29908071
[TBL] [Abstract][Full Text] [Related]
29. Quantification of total and unbound cefuroxime in plasma by ultra-performance liquid chromatography tandem mass spectrometry in a cohort of critically ill patients with hypoalbuminemia and renal failure.
van Raaij JJ; Mabelis NJD; Shudofsky KN; Meenks SD; le Noble JLML; Janssen PKC
J Clin Lab Anal; 2020 Mar; 34(3):e23100. PubMed ID: 31785116
[TBL] [Abstract][Full Text] [Related]
30. Nomogram based on actual body weight for estimation of vancomycin maintenance dose in infants.
Pokorná P; Šíma M; Černá O; Slanař O
Infect Dis (Lond); 2019 May; 51(5):334-339. PubMed ID: 30950674
[TBL] [Abstract][Full Text] [Related]
31. [Pharmacokinetics of vancomycin in neonates of postconceptional age less than or equal to 32 weeks].
Ginovart Galiana G; Mangues Bafalluy MA; Demestre Guasch X; Farré Riba R; Lopes Santos AP; Altirriba Valls O
An Esp Pediatr; 1996 Aug; 45(2):167-71. PubMed ID: 8967647
[TBL] [Abstract][Full Text] [Related]
32. Unbound fraction of vancomycin in intensive care unit patients.
Kees MG; Wicha SG; Seefeld A; Kees F; Kloft C
J Clin Pharmacol; 2014 Mar; 54(3):318-23. PubMed ID: 24000044
[TBL] [Abstract][Full Text] [Related]
33. Clinical pharmacokinetics of vancomycin in the neonate: a review.
Pacifici GM; Allegaert K
Clinics (Sao Paulo); 2012 Jul; 67(7):831-7. PubMed ID: 22892931
[TBL] [Abstract][Full Text] [Related]
34. Population pharmacokinetics of vancomycin in neonates.
Seay RE; Brundage RC; Jensen PD; Schilling CG; Edgren BE
Clin Pharmacol Ther; 1994 Aug; 56(2):169-75. PubMed ID: 8062493
[TBL] [Abstract][Full Text] [Related]
35. Vancomycin dosing: assessment of time to therapeutic concentration and predictive accuracy of pharmacokinetic modeling software.
Nunn MO; Corallo CE; Aubron C; Poole S; Dooley MJ; Cheng AC
Ann Pharmacother; 2011 Jun; 45(6):757-63. PubMed ID: 21652786
[TBL] [Abstract][Full Text] [Related]
36. Assessment of optimal initial dosing regimen with vancomycin pharmacokinetics model in very low birth weight neonates.
Kato H; Hagihara M; Nishiyama N; Koizumi Y; Mikamo H; Matsuura K; Yamagishi Y
J Infect Chemother; 2017 Mar; 23(3):154-160. PubMed ID: 28017667
[TBL] [Abstract][Full Text] [Related]
37. Validation of the effectiveness of a vancomycin nomogram in achieving target trough concentrations of 15-20 mg/L suggested by the vancomycin consensus guidelines.
Kullar R; Leonard SN; Davis SL; Delgado G; Pogue JM; Wahby KA; Falcione B; Rybak MJ
Pharmacotherapy; 2011 May; 31(5):441-8. PubMed ID: 21923425
[TBL] [Abstract][Full Text] [Related]
38. The pharmacokinetic/pharmacodynamic rationale for administering vancomycin via continuous infusion.
Waineo MF; Kuhn TC; Brown DL
J Clin Pharm Ther; 2015 Jun; 40(3):259-65. PubMed ID: 25865426
[TBL] [Abstract][Full Text] [Related]
39. Population pharmacokinetics of unbound hydrocortisone in critically ill neonates and infants with vasopressor-resistant hypotension.
Vezina HE; Ng CM; Vazquez DM; Barks JD; Bhatt-Mehta V
Pediatr Crit Care Med; 2014 Jul; 15(6):546-53. PubMed ID: 24797719
[TBL] [Abstract][Full Text] [Related]
40. Vancomycin cerebrospinal fluid concentrations after intravenous administration in premature infants.
Reiter PD; Doron MW
J Perinatol; 1996; 16(5):331-5. PubMed ID: 8915929
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
